Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-NS-19-028

Accelerating Medicine Partnership in Parkinsons disease (AMP PD) unbiased proteomics biofluid analysis (U01 Clinical Trials Not Allowed)

Closed on May 29, 2019.

Posted
April 5, 2019
Close date
May 29, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,860,708 in first-year total cost, median $1,860,708.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-B (72)]1

Most frequent institutions

  1. CEDARS-SINAI MEDICAL CENTER1
Competing awards under RFA-NS-19-028 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Post-translational modification and protein quantification of plasma and CSF1U01NS115658-01SOBHANI, KIMIAVAN EYK, JENNIFER ECEDARS-SINAI MEDICAL CENTER, CA$1,860,708ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-NS-19-028: Accelerating Medicine Partnership in Parkinsons disease (AMP PD) unbiased proteomics biofluid analysis (U01 Clinical Trials Not Allowed) | ScienceDex | ConductScience